[Guidelines for the diagnosis and treatment of the fibromyalgia syndrome].

Jacob N. Ablin, Howard Amital, Michael Ehrenfeld, Valerie Aloush, Ori Elkayam, Pnina Langevitz, Dror Mevorach, Reuven Mader, Tali Sachar, Daniela Amital, Dan Buskila, Rheumatology Association Israeli Rheumatology Association

Research output: Contribution to journalArticlepeer-review

Abstract

Over the past years, considerable progress has been made in understanding the pathogenesis of the fibromyatgia syndrome and the evidence based approach to the diagnosis and management has been significantty extended. The purpose of the current project is to develop practicat and evidence based guidetine recommendations for the Israeli health care system. A panet of physicians with clinical and research experience in the fibromyalgia field was convened under the auspices of the Israeli Rheumatology Association. A systematic review was performed on the current literature regarding the diagnosis and treatment of fibromyalgia. Using an interactive discussion procedure, recommendations were reached and expert opinion was introduced where evidence was considered incomplete. The panel recommendations underline the importance of concomitant and integrated medical therapy, such as serotonin and noradrenaline reuptake inhibitor (SNRI) anti-depressants or gamma-aminobutyric acid (GABA) related anti-epileptics, with regular aerobic physical exercise.

Original languageEnglish
Pages (from-to)742-747, 751, 750
JournalUnknown Journal
Volume152
Issue number12
StatePublished - Dec 2013
Externally publishedYes

Fingerprint

Dive into the research topics of '[Guidelines for the diagnosis and treatment of the fibromyalgia syndrome].'. Together they form a unique fingerprint.

Cite this